LRRK2 kinase modulates glucose-stimulated insulin secretion via RAB8 phosphorylation and ciliogenesis

Nevia Dule1, Algerta Marku1, Alessandra Galli1

  • 1Laboratory of Molecular and Cellular Physiology, Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Trentacoste 2, 20134, Milan, Italy.

Insights

Leucine-rich repeat kinase 2 (LRRK2) influences insulin secretion in pancreatic cells. Mutations linked to Parkinson's disease affect this process, suggesting peripheral roles in neurodegeneration.

Area of Science:

  • Endocrinology
  • Neuroscience
  • Cell Biology

Background:

  • Leucine-rich repeat kinase 2 (LRRK2) mutations are genetic risk factors for Parkinson's disease (PD).
  • LRRK2 is expressed in the endocrine pancreas, but its function there is unknown.
  • Parkinson's disease is an age-related neurodegenerative disorder.

Purpose of the Study:

  • To investigate the role of LRRK2 in pancreatic β-cell function.
  • To determine if LRRK2 kinase activity regulates insulin secretion.
  • To explore the mechanism by which LRRK2 influences hormone secretion.

Main Methods:

  • Pharmacological inhibition and activation of LRRK2.
  • Molecular approaches to study LRRK2 function.
  • In vitro models of pancreatic β-cells.
  • Transgenic mouse models with PD-associated LRRK2 mutations.

Main Results:

  • LRRK2 kinase activity regulates stimulated insulin secretion by affecting secretory granule trafficking.
  • The PD-associated G2019S LRRK2 mutant enhances basal insulin release.
  • LRRK2 kinase activity influences primary cilium formation and RAB8 recruitment in a glucose-dependent manner.

Conclusions:

  • LRRK2 is identified as a regulator of insulin secretion in pancreatic β-cells.
  • LRRK2's role in peripheral insulin secretion may contribute to Parkinson's disease development.
  • Dysregulation of LRRK2 in pancreatic cells could link metabolic dysfunction to neurodegeneration.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K